publication date: Jun. 22, 2016

Conversation with The Cancer Letter

Guideline Edits Rooted in Science, Former USPSTF Member Says

 

“I don’t see this recommendation as differing in any substantial way from some others that we’ve made, where we suggested that patients talk with their clinicians, and the important messages here is that colorectal cancer screening works, that colorectal cancer screening reduces deaths from colorectal cancer,” said Douglas Owens, a who has rotated off the U.S. Preventive Services Task Force, and was involved in developing the colorectal cancer screening guideline published earlier this week.

“The draft guideline, as you know, was a recommendation for screening for colorectal cancer, and we got comments from a broad variety of people,” Owens said. “What we saw from the comments that in our original draft, the distinction between recommended and alternative tests was confusing to both clinicians and patients.

“In reviewing those comments, we decided that that language was confusing people, so we decided to eliminate it.”

Owens is the Henry J. Kaiser, Jr. Professor and director of the Center for Health Policy in the Freeman Spogli Institute for International Studies and of the Center for Primary Care and Outcomes Research in the Department of Medicine and School of Medicine at Stanford University. He is a general internist and associate director of the Center for Innovation to Implementation, a health services research center of excellence, at the VA Palo Alto Health Care System. Owens is a professor of medicine and, by courtesy, professor of health research and policy, and a professor … Continue reading 42-24 Guideline Edits Rooted in Science, Former USPSTF Member Says

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.